Enhertu is primarily used to treat HER2-positive breast cancer and gastric cancer, but it has shown promising results in treating other HER2-positive tumors, including NSCLC and other solid tumors[6,12]. Here, ERBB2 is linked to non-small cell lung carcinoma.